Jia et al. presented a comprehensive overview of the JAK-STAT pathway, covering its composition, activation mechanisms, dynamic interactions, and the molecular drivers behind its abnormal activation in lung cancer (LC). The gene discussed is SOAT1; the disease is lung carcinoma.